Micro Therapeutics provides invasive medical devices for the diagnosis and treatment of vascular diseases. It provides devices pertaining to the treatment of neurovascular disorders of the brain associated with stroke. It is also focused on the treatment of peripheral vascular disease, including blood clot therapy in hemodialysis access grafts, arteries, and veins. Its neurovascular product portfolio includes Sapphire and Sapphire NXT detachable coils that were developed to treat brain aneurysms; Onyx, which is a liquid embolic that was developed to treat brain aneurysms and arterial-venous malformations; and delivery products, including guidewires, balloon catheters, and micro catheters, and more. It also provides a mechanical thrombolytic device for interventional clot disruption and dissolution. Micro Therapeutics was established in 1968, based in Irvine, California. It delivers its products to radiologists and neuroradiologists primarily in the United States, Canada, the European Union, and Japan. Micro Therapeutics currently operates as a subsidiary of Covidien plc.

The Population Council is an international, nonprofit, non-governmental organization. The Council conducts research in biomedicine, social science, and public health and helps build research capacities in developing countries. One-third of its research relates to HIV and AIDS; while its other major program areas are in reproductive health and its relation to poverty, youth, and gender. For example, the Population Council strives to teach boys that they can be involved in contraceptive methods regardless of stereotypes that limit male responsibility in child bearing. The organization held the license for Norplant contraceptive implant, and now holds the license for Mirena intrauterine system. The Population Council also publishes the journal Population and Development Review, which reports scientific research on the interrelationships between population and socioeconomic development. It also provides a forum for discussion on related issues of public policy and Studies in Family Planning, which focuses on public health, social science, and biomedical research involving sexual and reproductive health, fertility, and family planning.

Contraline, Inc. is a medical device company, which engages in the development of novel hydrogels for reproductive and contraceptive applications. Its Echo-VR product applies hydrogel technology to physically block sperm within the male reproductive tract. The company was founded by Kevin Eisenfrats and John C. Herr in 2015 and is headquartered in Charlottesville, VA.

$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional, transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.

Femcare Ltd. manufactures and distributes medical devices. It develops products for male sterilisation and female urology. The company was founded in 1982 and is located in Nottingham, UK.

Ovion, Inc., a subsidiary of Endo International Plc, is a company headquartered in Minnetonka, MN, that develops transcervical sterilization technology. Astora Women's Health, Inc. acquired Ovion, Inc. on July 07, 2005 for $10 million.

Rimon Therapeutics Ltd. develops and markets pharmaceutical products. The company was founded by Michael May and is headquartered in Mississauga, Canada.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

AMS Research Corp., a subsidiary of Endo International Plc, is a company headquartered in the United States specializing in surgical and medical instruments and apparatus.

The International Development Research Centre (IDRC) funds research in developing countries to promote growth, reduce poverty, and drive large-scale positive change. A Crown corporation, they support leading thinkers who advance knowledge and solve practical development problems. They provide the resources, advice, and training they need to implement and share their solutions with those who need them most. In short, IDRC increases opportunities — and makes a real difference in people’s lives. Working with their development partners, they multiply the impact of their investment and bring innovations to more people in more countries around the world. They offer fellowships and awards to nurture a new generation of development leaders. Their head office is located in Ottawa, Canada, while four regional offices keep us close to their work. They are located in Montevideo, Uruguay; Nairobi, Kenya; Amman, Jordan; and New Delhi, India. IDRC is governed by a board of up to 14 governors, whose chairperson reports to Parliament through the Minister of International Development. IDRC was established by an act of Canada’s parliament in 1970 with a mandate “to initiate, encourage, support, and conduct research into the problems of the developing regions of the world and into the means for applying and adapting scientific, technical, and other knowledge to the economic and social advancement of those regions.”

Sofradim Production SAS manufactures medical, surgical and dental equipment. The company is headquartered in Trevoux, France.

Bayer HealthCare Ltd., established on 1995-08-25, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;food sales;Health food production;food production;Production of formula food for special medical purpose;Cosmetic production;Production of hygiene products and single-use medical products;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Wholesale;Cosmetics Retail;internet sales(Except for products that require a license for sale);Food import and export;software development;software sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Manufacturing of computer software, hardware and peripheral equipment;Software outsourcing service;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Special Equipment Repair;Import and export;Technology Import and Export;Import and export agency;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Family Health International offers technical and research services. It offers capacity building, creative services, data analysis, emerging infectious diseases and pandemic response, monitoring and evaluation, quality assurance, research services, social and behavior change, social marketing and communication, and training and technical assistance. The company was founded in 1971 and is headquartered in Durham, NC.

Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. After World War II, Ethicon's market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%.